Supervised Endoscopic Tele-controlled Intelligent Lithotripsy
ConditionRenal Stone
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age19+
SponsorChinese University of Hong Kong
About this trial
This is a phase I feasibility study to investigate the use of a novel intelligent robotic retrograde intrarenal surgery (RIRS) platform. The TaloStone T1000 RIRS system can manipulate the flexible ureteroscope, with remote control of the instruments (laser fibre or basket) and ureteral access sheath movements. Beyond teleoperation, the TaloStone T1000 RIRS system integrates AI perception models and decision-making algorithms to enable the supervised autonomous execution of critical tasks within the RIRS workflow.
Eligibility criteria
Qualifiers
Adult patients >18 years old
Renal stone(s) less than 1cm 2cm in maximal length
Clinically indicated for RIRS
Willingness to participate as demonstrated by giving informed consent
Disqualifiers
Patients with no preoperative CT imaging available
Patients who are not recommended to receive RIRS
Severe concomitant illness that drastically shortens life expectancy or increases risk of therapeutic intervention
Untreated active infection
Trial design
Treatments tested in this trial
- RIRS using the TaloStone T1000 RIRS platform
Treatment groups
15 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov